Skip to main content
Log in

Testicular seminoma: 20-year experience at the Northern Israel Oncology Center (1968–1988)

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Eighty-four patients with testicular seminoma were treated at the Northern Israel Oncology Center during the years 1968–1988. Using the staging classification of Hussey, 69 patients (82%) had Stage I, eight (10%) had Stage IIA, four (5%) had Stage IIB, one (1%) had Stage IIIA, and two (2%) had Stage IIIB disease. Sixtynine patients (82%) had classic pure seminoma, nine (11%) had anaplastic seminoma and six (7%) had spermatocytic seminoma. Seventy-four patients (88%) underwent high inguinal orchiectomy and ten (12%) had a scrotal approach. Seventy-five patients (85%) were treated with postoperative irradiation. Stage I patients received 26–30 Gy to the paraaortic and ipsilateral pelvic lymph nodes. Stage IIA patients were treated in the same manner with a boost to the involved lymph nodes. With a mean follow-up of 97 months, 65 patients (77%) are alive and well with no evidence of disease, 7 patients (8%) are dead due to disease progression. The 5-, 10-, 15-, and 20-year actuarial survival for all patients was 90%, and for early stage patients 94%. Eight patients (14%) relapsed; 3 of them were salvaged by chemotherapy.

Serious side effects of irradiation included lethal respiratory failure due to bleomycin-induced pulmonary fibrosis in one patient, peptic ulcer in three patients, hydronephrosis due to paraureteral fibrosis in one patient and recurrent paralytic ileus in one patient. Eight patients (10%) developed nine second cancers, three of them within the previous radiation field.

It is concluded that appropriate planning and adequate radiation dose can yield a 20-year disease-free survival rate for more than 90% of patients with early stage testicular seminoma. Accurate staging may prevent overtreatment, thus reducting long-term toxicity. Because of the risk of developing a second primary cancer, careful follow-up monitoring with a high index of suspicion for such disorders is warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Peckham, M. J.: Testicular tumours: Investigation and staging classification. In: M. J. Peckham (ed.), The Management of Testicular Tumours. Edward Arnold Ltd., London 1981, pp. 89–101.

    Google Scholar 

  2. Sommer, K., Brockmann, W. P., Hubener, K. H.: Treatment results and acute and late toxicity of radiation therapy for testicular seminoma.Cancer, 66, 259 (1990).

    Article  PubMed  CAS  Google Scholar 

  3. Hunter, M., Peschel, R. E.: Testicular seminoma. Results of the Yale University experience, 1964–1984.Cancer, 64, 1608 (1989).

    Article  PubMed  CAS  Google Scholar 

  4. Hussey, D. H.: Testis. In: G. H. Fletcher (ed.): Textbook of Radiotherapy. Lea and Febiger, Philadelphia 1980, pp. 867–886.

    Google Scholar 

  5. Stein, M., Steiner, M., Kuten, A., Cohen, J., Robinson, E.: Testicular seminoma: Results of treatment at the Northern Israel Oncology Center.Oncology, 43, 89 (1986).

    PubMed  CAS  Google Scholar 

  6. Hussey, D. H.: Testicular cancer. In: Levitt, S. H., Khan, F. M., Potish, R. A. (eds.): Levitt and Tapley’s Technological Basis of Radiation Therapy: Practical Clinical Applications (2nd Ed). Lea and Febiger, Philadelphia/London 1992, pp. 323–335.

    Google Scholar 

  7. Kaplan, E. L., Meier, P.: Non-parametric estimation from incomplete observations.J. Am. Stat. Assoc., 53, 457 (1958).

    Article  Google Scholar 

  8. Einhorn, L. H., Donohue, J. P.: Cis-diamminedichloroplatinum, Vinblastine and Bleomycin combination chemotherapy in disseminated testicular cancer.Ann. Intern. Med., 87, 293 (1977).

    PubMed  CAS  Google Scholar 

  9. Cionini, L., Ciatt, S., Pitrioli, L., Santoni, R., Cappellini, M.: Radiotherapy of seminoma of the testis. Report on 129 patients.Tumori, 64, 183 (1978).

    PubMed  CAS  Google Scholar 

  10. Thomas, G. M., Sturgeon, J. F., Alison, R., Jewett, M., Goldberg, L., Sugar, L., Rideout, D., Gospodarowicz, M. K., Duncan, W. A.: Study of post-orchidectomy surveillance in Stage I testicular seminoma.J. Urol., 142, 313 (1989).

    PubMed  CAS  Google Scholar 

  11. Zagars, G. K., Babaian, R. J.: Stage I testicular seminoma: Rationale for post-orchidectomy radiation therapy.Int. J. Rad. Oncol. Biol. Phys., 13, 155 (1987).

    CAS  Google Scholar 

  12. Bobba, V. S., Mittal, B. B., Hoover, S. V., Kepka, A.: Classical and anaplastic seminoma: Difference in survival.Radiology, 167, 849 (1988).

    PubMed  CAS  Google Scholar 

  13. Epstein, B. E., Order, S. E., Zinreich, E. S.: Staging, treatment and results in testicular seminoma: A 12-year report.Cancer, 65, 405 (1990).

    Article  PubMed  CAS  Google Scholar 

  14. Crawford, E. D., Smith, R. B., deKernion, J. B.: Treatment of advanced seminoma with pre-radiation chemotherapy.J. Urol., 129, 752 (1983).

    PubMed  CAS  Google Scholar 

  15. Thomas, G. M.: Controversies in the management of testicular seminoma.Cancer, 55, 2296 (1985).

    Article  PubMed  CAS  Google Scholar 

  16. Hamilton, C., Horwich, A., Easton, D., Peckham, M. J.: Radiotherapy for Stage I seminoma testis: Results of treatment and complications.Radiother. Oncol., 6, 115 (1986).

    Article  PubMed  CAS  Google Scholar 

  17. Thomas, G. M., Rider, W. D., Dembo, A. J., Cummings, B. J., Gospodarowicz, M., Hawkins, N. V., Herman, J. G., Keen, C. W.: Seminoma of the testis: Results of treatment and patterns of failure after radiation therapy.Int. J. Rad. Oncol. Biol. Phys., 8, 165 (1982).

    CAS  Google Scholar 

  18. Lederman, G. S., Herman, T. S., Jockelson, M., Silver, B. J., Chaffey, J. T., Garnick, M. B., Richie, J., Sheldon, T. A., Coleman, C. N.: Radiation therapy of seminoma: 17-year experience at the Joint Centre for Radiation Therapy.Radiother. Oncol., 14, 203 (1989).

    Article  PubMed  CAS  Google Scholar 

  19. Hellbardt, A., Mirimanoff, R. O., Obradovic, M., Mermillod, B., Panmier, J. P.: The risk of second cancer in patients treated for testicular seminoma.Int. J. Rad. Oncol. Biol. Phys., 18, 1327 (1990).

    CAS  Google Scholar 

  20. Hay, J. H., Duncan, W., Kerr, G. R.: Subsequent malignancies in patients irradiated for testicular tumours.Br. J. Radiol., 57, 597 (1984).

    Article  PubMed  CAS  Google Scholar 

  21. Hamilton, C., Horwich, A., Bliss, M. J.: Gastrointestinal morbidity of adjuvant radiotherapy in Stage I malignant teratoma of the testis.Radiother. Oncol., 10, 85 (1987).

    Article  PubMed  CAS  Google Scholar 

  22. Coia, L. R., Hanks, G. E.: Complications from large-field intermediate dose infradiaphragmatic radiation: An analysis of the patterns of care outcome studies for Hodgkin’s disease and seminoma.Int. J. Rad. Oncol. Biol. Phys., 15, 29 (1988).

    CAS  Google Scholar 

  23. Prosnitz, L. R.: Radiation complications for Hodgkin’s disease and seminoma: Assessing the risk: benefit ratio.Int. J. Rad. Oncol. Biol. Phys., 15, 239 (1988).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stein, M., Steiner, M., Moshkowitz, B. et al. Testicular seminoma: 20-year experience at the Northern Israel Oncology Center (1968–1988). International Urology and Nephrology 26, 461–469 (1994). https://doi.org/10.1007/BF02768019

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02768019

Keywords

Navigation